NCT05928962
An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas treatment 1 enrolling_by_invitation NCT06299163
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT03454282
Impact of Dietary Intervention on Tumor Immunity: the DigesT Trial No drug interventions treatment Not Available unknown_status NCT05551117
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors treatment 2 active_not_recruiting NCT06332755
Study to Evaluate LB-LR1109 for the Treatment of Solid Tumors No drug interventions treatment 1 recruiting NCT06613230
Improved Early Diagnosis in Female Pelvic Cancer With OC Detect No drug interventions Not Available Not Available recruiting NCT01271803
A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma treatment 1 completed NCT01962103
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors treatment 1 / 2 completed NCT00651703
Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients treatment 2 completed NCT02935790
Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab treatment 1 completed NCT00963664
Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma treatment 2 withdrawn NCT00616564
Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma No drug interventions treatment 2 completed NCT04382664
UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma treatment 2 completed NCT00179764
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) No drug interventions treatment Not Available completed NCT01253564
A Study of RO5185426 in Previously Treated Melanoma Patients With Brain Metastases treatment 2 completed NCT01543464
Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients treatment 2 terminated NCT00949702
A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma treatment 2 completed NCT02828202
Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary No drug interventions Not Available Not Available recruiting NCT02223884
A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy treatment 2 completed NCT06294379
Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy No drug interventions Not Available Not Available recruiting NCT04879654
Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery No drug interventions treatment 2 recruiting NCT00034554
Study of gp75 Vaccine in Patients With Stage III and IV Melanoma No drug interventions treatment 1 completed NCT00864253
A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma treatment 3 completed NCT04460053
Neurofilament Light Protein in Peripheral Blood Used as a Biomarker for Neurotoxicity After Isolated Limb Perfusion. No drug interventions diagnostic Not Available completed NCT00087477
A Pilot Study of Pivanex in Patients With Malignant Melanoma treatment 1 / 2 terminated NCT00733798
A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma treatment 1 / 2 terminated NCT00350597
GM-CSF as Adjuvant Therapy of Melanoma No drug interventions treatment 2 completed NCT00601861
Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer treatment 2 terminated NCT00715793
Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma treatment 1 / 2 completed NCT02535078
Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma treatment 1 / 2 withdrawn NCT03607578
Test of Interventions to Prevent Skin Cancer Among Danes on Vacation in High UV Index Sunny Destinations No drug interventions prevention Not Available completed NCT04543188
A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement treatment 1 terminated NCT01164007
A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma treatment 2 completed NCT06206707
FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis No drug interventions treatment Not Available recruiting NCT00052156
Vaccine Therapy for Patients With Stage IV Melanoma treatment 3 unknown_status NCT00044356
Phase II Trial of Allovectin-7® for Metastatic Melanoma No drug interventions treatment 2 completed NCT03966456
Real World Study of Four PD-1 Agents in China No drug interventions Not Available Not Available unknown_status NCT01359956
Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma treatment 3 completed NCT05389085
Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping No drug interventions diagnostic Not Available completed NCT03383237
Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma treatment 2 unknown_status NCT01321437
Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma treatment 2 completed NCT05098132
Phase 1a/1b Study of STK-012 Monotherapy and in Combination With Pembrolizumab in Patients With Solid Tumors treatment 1 recruiting NCT00855452
Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors No drug interventions treatment 2 completed NCT00327600
Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma treatment 1 / 2 completed NCT02537600
Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis treatment 2 completed NCT02661100
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients treatment 1 / 2 withdrawn NCT01455259
Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors No drug interventions treatment 1 / 2 completed NCT04123470
A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma treatment 1 / 2 completed NCT02902042
Encorafenib + Binimetinib + Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma treatment 1 / 2 completed NCT01656642
A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma treatment 1 completed NCT02938299
Neoadjuvant L19IL2/L19TNF- Pivotal Study treatment 3 recruiting NCT01001299
A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma treatment 1 completed NCT02143999
An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma No drug interventions Not Available Not Available completed NCT01137006
An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma No drug interventions treatment 1 completed NCT00323206
Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant Melanoma No drug interventions treatment Not Available completed NCT00370136
Sentinel Node With Ultrasound Contrast in Melanoma No drug interventions diagnostic Not Available completed NCT00498836
Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma treatment 2 completed NCT02523313
Immunotherapy With Nivolumab or Nivolumab Plus Ipilimumab vs. Double Placebo for Stage IV Melanoma w. NED treatment 2 completed NCT00978913
Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma treatment 1 completed NCT04889118
Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study treatment 3 active_not_recruiting NCT00358319
Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma treatment 1 / 2 terminated NCT01689519
A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma treatment 3 completed NCT01124734
High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma treatment 2 completed NCT00204516
Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens No drug interventions treatment 1 / 2 completed NCT02275416
Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma treatment 1 / 2 active_not_recruiting NCT00111696
Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma treatment 1 completed NCT02296996
Dabrafenib and Trametinib for BRAF-inhibitor Pretreated Patients treatment 2 completed NCT01253096
Intratumoral Application of L19IL2 in Patients With Malignant Melanoma treatment 2 completed NCT00287196
Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes No drug interventions treatment 3 completed NCT05293496
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors treatment 1 recruiting NCT00145158
Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma treatment 1 / 2 terminated NCT02410863
Biopsy- and Biology-driven Optimization of Targeted Therapy in Subjects With Advanced Melanoma treatment 2 terminated NCT04648163
Suction Drain in Axillary Lymph Node Dissection for Malignant Melanoma No drug interventions Not Available Not Available completed NCT00336986
Efficacy Study of IL-21 to Treat Metastatic Melanoma No drug interventions treatment 2 completed NCT05664139
Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma treatment 2 not_yet_recruiting NCT05037825
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors No drug interventions Not Available Not Available recruiting NCT00052130
Vaccine Therapy for Patients With Stage III Melanoma treatment 3 unknown_status NCT01990248
An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS) No drug interventions Not Available Not Available completed NCT04079166
SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study) treatment 2 recruiting NCT00306566
Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients No drug interventions Not Available 1 / 2 completed NCT03448666
ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases treatment 2 recruiting NCT03278665
4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy treatment 1 / 2 completed NCT04913220
A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) treatment 1 / 2 active_not_recruiting NCT00235482
Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma (PXS-X02) treatment 1 completed NCT04217382
Pre Transplantation Melanoma No drug interventions Not Available Not Available completed NCT06270082
Study of IK-595 in RAS- or RAF-altered Advanced Tumors No drug interventions treatment 1 recruiting NCT01024231
Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma treatment 1 completed NCT04126876
A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma treatment 2 recruiting NCT01002560
The Identification of Novel Prognostic Markers in Melanoma No drug interventions Not Available Not Available unknown_status NCT01636960
A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370) No drug interventions treatment 1 terminated NCT00204594
Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28 No drug interventions treatment 1 / 2 completed NCT02718391
Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients. No drug interventions treatment 2 terminated NCT06209580
AMT-253 in Patients With Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT01264380
A Study of the Effect of Food on the Pharmacokinetics of Single Dose RO5185426 And the Safety And Efficacy of Continuous Administration in Patients With BRAF V600E Mutation-Positive Metastatic Melanoma treatment 1 completed NCT01006980
A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3) treatment 3 completed NCT03649529
Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy No drug interventions treatment 0 unknown_status NCT03563729
Melanoma Metastasized to the Brain and Steroids treatment 2 recruiting NCT02709889
Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors treatment 1 / 2 terminated NCT00299689
Phase II Trial of Ontak With Metastatic Melanoma treatment 2 completed NCT02650492
Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma No drug interventions treatment Not Available terminated NCT04282044
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies treatment 1 recruiting NCT01278940
Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma No drug interventions treatment 1 / 2 completed NCT03084640
Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Participants With Advanced Melanoma treatment 1 completed NCT01065467
Panobinostat (LBH589) in Patients With Metastatic Melanoma treatment 1 completed NCT00924001
Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma treatment 1 / 2 terminated NCT00513604
Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma treatment 2 completed NCT02612168
Melanoma Image Analysis Algorithm (MIAA) Validation Study No drug interventions diagnostic Not Available completed NCT01435369
Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma treatment 2 completed NCT00060710
CP-461 in the Treatment of Patients With Advanced Melanoma No drug interventions treatment 2 terminated NCT01910181
A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma treatment 1 completed NCT06553781
A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma treatment Not Available not_yet_recruiting NCT03034395
Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma No drug interventions treatment Not Available completed NCT00535314
Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma treatment 2 withdrawn NCT03538314
UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma No drug interventions treatment 1 completed NCT01077050
SciBase International Melanoma Pivotal Study No drug interventions diagnostic Not Available completed NCT00991250
SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma treatment 2 unknown_status NCT03780608
This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO) treatment 2 unknown_status NCT00179608
Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy treatment 1 completed NCT00911443
Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma treatment 2 completed NCT01522664
A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma No drug interventions treatment 1 completed NCT06150664
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT02050321
A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma treatment 2 terminated NCT00104884
FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma treatment 2 terminated NCT01704287
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002) treatment 2 completed NCT00405587
Safety Study of PLX4032 in Patients With Solid Tumors treatment 1 completed NCT02574533
Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma treatment 1 completed NCT02434354
A Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma treatment 1 completed NCT00142454
NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting) treatment 1 completed NCT02303951
Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC treatment 2 terminated NCT01227551
A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM ) treatment 2 completed NCT03178851
Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma treatment 1 completed NCT00306553
Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients No drug interventions Not Available 2 completed NCT04229277
Fast Track Diagnosis of Skin Cancer by Advanced Imaging No drug interventions diagnostic Not Available completed NCT01588847
Anesthesia and Cancer Recurrence im Malignant Melanoma No drug interventions treatment Not Available unknown_status NCT01696045
Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma treatment 2 terminated NCT00145145
Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma treatment 1 / 2 terminated NCT05144698
RAPA-201 Therapy of Solid Tumors treatment 1 / 2 recruiting NCT01167998
Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions No drug interventions Not Available Not Available unknown_status NCT06560905
Preoperative Planning With PSMA-PET in Melanoma Surgery Trial No drug interventions diagnostic 2 not_yet_recruiting NCT01307397
A Study of Vemurafenib in Participants With Metastatic Melanoma treatment 3 completed NCT04884997
A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma treatment 2 recruiting NCT04763083
First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies No drug interventions treatment 1 recruiting NCT02889861
IMCgp100-401 Rollover Study treatment 2 terminated NCT00963261
Quality of Life and Psychological Well-being in Patients With Malignant Melanoma No drug interventions diagnostic Not Available unknown_status NCT02938728
Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma No drug interventions Not Available Not Available unknown_status NCT00204607
Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients No drug interventions treatment 1 / 2 completed NCT03060356
Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET) No drug interventions treatment 0 terminated NCT05756556
T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma treatment 2 suspended NCT04904185
ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma treatment 1 terminated NCT01017185
Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions No drug interventions treatment 1 completed NCT01898585
An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma treatment 4 completed NCT04593485
Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract treatment 2 unknown_status NCT00710515
Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies treatment 1 completed NCT00441337
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies treatment 1 completed NCT05172232
Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions No drug interventions Not Available Not Available completed NCT00039000
Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma treatment 3 completed NCT02829775
A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies treatment 2 / 3 completed NCT00108875
Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer No drug interventions treatment 1 / 2 unknown_status NCT01378975
A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases treatment 2 completed NCT05089370
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma treatment 1 / 2 recruiting NCT02673970
Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma No drug interventions Not Available Not Available recruiting NCT02186249
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma Not Available Not Available no_longer_available NCT04285749
Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas treatment 0 withdrawn NCT03197636
Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients Not Available Not Available completed NCT01248936
A Study of RO5185426 in Patients With Metastatic Melanoma treatment 2 completed NCT04924413
L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma treatment 2 terminated NCT01107418
A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma treatment 1 completed NCT01559818
A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001 treatment 1 / 2 terminated NCT03409419
PET Imaging of the Immune System Using Analog Probes Not Available Not Available completed NCT03653819
High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs No drug interventions supportive_care Not Available completed NCT00145041
Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction treatment 1 completed NCT02331134
Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer basic_science Not Available active_not_recruiting NCT03545334
Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study No drug interventions diagnostic Not Available completed NCT02068196
A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma. treatment 4 active_not_recruiting NCT04074096
Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis treatment 2 active_not_recruiting NCT03903458
Tinostamustine and Nivolumab in Advanced Melanoma treatment 1 unknown_status NCT03158935
The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial treatment 1 completed NCT03236935
Phase Ib of L-NMMA and Pembrolizumab treatment 1 active_not_recruiting NCT00116363
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma No drug interventions treatment 2 unknown_status NCT01288963
IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma Not Available Not Available completed NCT03820986
Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advance Melanoma (MK-7902-003/E7080-G000-312/LEAP-003) treatment 3 active_not_recruiting NCT01898039
Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients treatment 1 / 2 unknown_status NCT06265025
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT04223648
Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma basic_science 0 withdrawn NCT00232726
Clinical Study of Previously Untreated Patients With Malignant Melanoma treatment 2 completed NCT03551626
Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes treatment 3 completed NCT00540566
Optical Biopsy of Human Skin in Conjunction With Laser Treatment No drug interventions Not Available Not Available completed NCT02784366
GI Complications in Cancer Immunotherapy Patients No drug interventions Not Available Not Available unknown_status NCT02897765
A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer treatment 1 completed NCT04253574
Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma No drug interventions Not Available Not Available completed NCT00966173
International Melanoma Algorithm Training Study - IMATS No drug interventions diagnostic Not Available completed NCT01069627
A Study of Avastin (Bevacizumab) in Combination With Fotemustine in Patients With Metastatic Melanoma treatment 2 completed NCT00294476
IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma No drug interventions treatment 2 unknown_status NCT05478876
Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract No drug interventions treatment Not Available recruiting NCT00087776
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma No drug interventions treatment Not Available completed NCT01744860
Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples No drug interventions Not Available Not Available completed NCT02452294
Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER) treatment 2 unknown_status NCT00539591
Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma treatment 2 active_not_recruiting NCT01164891
A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic Melanoma treatment 1 completed NCT01211262
Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma treatment 1 completed NCT02902029
Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma treatment 2 completed NCT03332589
E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS) treatment 1 terminated NCT04293289
Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma No drug interventions treatment Not Available completed NCT00086489
CP-675,206 In Patients With Advanced Melanoma treatment 2 completed NCT03689192
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors No drug interventions treatment 1 completed NCT02071940
PLX3397 KIT in Acral aNd mucOsal Melanoma treatment 2 completed NCT02459067
ImmuniCell® in Patients With Advanced Cancers No drug interventions treatment 2 terminated NCT01307267
A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab treatment 1 completed NCT00483301
A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma treatment 2 completed NCT00631072
In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer No drug interventions treatment 1 completed NCT00324272
Post-Operative Drainage Following Lymph Node Dissection treatment 4 completed NCT02644369
Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors treatment 2 active_not_recruiting NCT05304546
Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma treatment 2 not_yet_recruiting NCT04547946
Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib) Not Available Not Available completed NCT03116412
A Randomized Trial to Assess the Role of Imaging During Follow up After Radical Surgery of High Risk Melanoma No drug interventions diagnostic Not Available recruiting NCT00300612
Vaccine Treatment for Advanced Malignant Melanoma No drug interventions treatment 1 / 2 completed NCT01138410
Study of a DNA Immunotherapy to Treat Melanoma treatment 1 / 2 terminated NCT01264081
Lapatinib in Stage IV Melanoma With ERBB4 Mutations treatment 2 terminated NCT02316795
Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma No drug interventions diagnostic 0 completed NCT01586195
Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E treatment 2 terminated NCT00826995
Comparison of Video-Based Versus Written Patient Education on Melanoma No drug interventions Not Available Not Available completed NCT00862914
Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic Naevi No drug interventions Not Available Not Available completed NCT01557114
Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma treatment 1 terminated NCT04452214
A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors treatment 1 completed NCT02272855
A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma treatment 2 completed NCT05130255
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2 No drug interventions treatment 1 recruiting NCT00729950
Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma treatment 1 completed NCT01519323
BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations treatment 1 terminated NCT01247623
Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma Not Available 1 / 2 completed NCT01480323
A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2 treatment 2 completed NCT00135408
A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide treatment 2 completed NCT00203008
A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma No drug interventions Not Available Not Available completed